US FDA to Authorize Covid-19 Pills of Pfizer and Merck This Week

The two pills, especially Paxlovid pill developed by Pfizer, has now been seen as the most promising new oral treatments, which can possibly be taken on the onset of the symptoms at the homes of the people for the purpose of providing help in preventing the hospitalizations and deaths related to the novel corona virus vaccine.

The Food and Drug Administration of the United States is all set for authorizing pills for the treatment of the novel corona virus from Merck and Pfizer, that has been citing the people, which are familiar with the matter.

The drug molnupiravir developed by Merck along with Ridgeback Biotherpeutics, had been shown for the decrease in the hospitalizations and deaths caused by the novel corona virus by around 30 percent in the clinical trials of the individuals of high risk early in the course of the illness of the disease.

The drug molnuporavir has now gained a narrow vote in the favour of the approval by a panel of the advisors to the United States FDA on 30^th November 2021, and the Food and Drug Association does not immediately responding to a request for giving any comments.

In the month of November 2021, the government of the United Kingdom for becoming the first country across the globe for approving the antiviral drug of Merck for use in the people, who are suffering with mild and moderate novel corona virus and the government of the United States is now having a contract for purchasing around 5 million courses of the pill developed my Merck.